0
ARTICLE |

NITROGEN MUSTARD THERAPY: Title and subTitle BreakUse of Methyl-Bis(Beta-Chloroethyl)amine Hydrochloride and Tris(Beta-Chloroethyl)amine Hydrochloride for Hodgkin's Disease, Lymphosarcoma, Leukemia and Certain Allied and Miscellaneous Disorders FREE

LOUIS S. GOODMAN, M.D.; MAXWELL M. WINTROBE, M.D.; WILLIAM DAMESHEK, M.D.; MORTON J. GOODMAN, M.D.MAJOR ; ALFRED GILMAN; MARGARET T. McLENNAN, M.D.
[+] Author Affiliations

The Jane Coffin Childs Fund for Medical Research, Yale University, defrayed part of the expenses of this investigation.

The chemicals employed in this study were generously supplied by Dr. Milton C. Winternitz, Chairman, Committee on the Treatment of Gas Casualties.

Reports of several of the investigations referred to either have not been published or have not been recorded in the open literature. The date given is the year in which the work was carried out.

The following physicians have generously cooperated in providing cases for study: Drs. Gustaf E. Lindskog, Grover F. Powers, Francis G. Blake, G. G. Richards, M. J. Taylor and L. A. Wheelwright.


Salt Lake City; Salt Lake City; Boston; Portland, Ore.; Medical Corps, Army of the United States; Salt Lake City

Dr. L. S. Goodman, Dr. Wintrobe and Dr. McLennan are from the University of Utah School of Medicine; Dr. Dameshek is from Tufts College Medical School; Dr. Morton J. Goodman is from the University of Oregon Medical School, and Major Gilman is from the Medical Research Division, Edgewood Arsenal.


JAMA. 1946;132(3):126-132. doi:10.1001/jama.1946.02870380008004
Text Size: A A A
Published online

In a recent report the historical aspects of the use of β-chloroethyl amines (halogenated alkyl amines, nitrogen mustards) in the treatment of certain diseases of the blood-forming organs were presented and the chemical, pharmacologic, toxicologic and animal experimental aspects of these compounds reviewed.1 The interested reader is referred to that report for orientation.

The present preliminary communication concerns the clinical use of halogenated alkyl amines in the treatment of lymphosarcoma, Hodgkin's disease, leukemia and a limited number of allied and miscellaneous disorders. In all, 67 patients have been studied. These include 7 patients2 treated by L. S. Goodman and Alfred Gilman at the New Haven Hospital; 34 patients treated by M. M. Wintrobe and Margaret T. McLennan at the Salt Lake County General Hospital; 16 patients treated by William Dameshek, Boston, and 10 patients treated by M. J. Goodman, Portland, Ore. The types of diseases treated are shown

REFERENCES

Gilman, A., and Philips, F. S.:  The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides , Science 103: 409-415, 1946;.
Gilman, A.; Goodman, L. S.; Philips, F. S., and Dougherty, T., 1943.
Dougherty, T.; Gilman, A., and Goodman, L. S., 1942. Unpublished observations.
Dr. Gustaf E. Lindskog, Department of Surgery, Yale University School of Medicine, gave the authors permission to study and report this case.
A complete description of this case has appeared elsewhere.2
Duran-Reynals, F.; Goodman, L. S., and Gilman, A., 1942. Unpublished observations.2

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Gilman, A., and Philips, F. S.:  The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides , Science 103: 409-415, 1946;.
Gilman, A.; Goodman, L. S.; Philips, F. S., and Dougherty, T., 1943.
Dougherty, T.; Gilman, A., and Goodman, L. S., 1942. Unpublished observations.
Dr. Gustaf E. Lindskog, Department of Surgery, Yale University School of Medicine, gave the authors permission to study and report this case.
A complete description of this case has appeared elsewhere.2
Duran-Reynals, F.; Goodman, L. S., and Gilman, A., 1942. Unpublished observations.2
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.